Doctors in Europe can continue to use Sanofi-Aventis SA's <SASY.PA> heparin medicine Lovenox, despite low levels of contamination found in some batches of the product, the European Medicines ...

Enoxaparin was associated with a lower risk of cardiovascular outcomes compared with unfractionated heparin in a nonrandomized substudy of the FINESSE trial.

Lovenox is a prescription drug used to treat or prevent certain types of blood clots. Learn how to lower long-term costs, and more.

The authors looked only at TIMI 11B patients for whom data on aPTT had been collected (n=1893) and compared the number of events and bleeding rates after 48 hours in patients on UFH to patients who ...

Why a non-substitutable generic? Because Lovenox is a complex biological drug, Viehbacher said, and regulators will have to carefully study any copies to make sure they're safe and effective. And ...

Pending a final decision on the merits of the underlying complaint, sanofi-aventis will continue to make original enoxaparin (Lovenox®) available to healthcare professionals for their patients.

Techdow USA is introducing 30 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg and 150 mg strengths of generic Enoxaparin Sodium (Preservative Free) Prefilled Syringes, which is the generic of Sanofi ...

The patient was given two doses of the blood thinner Lovenox in March at Adventist Health Simi Valley over just two hours instead of the recommended 12-hour separation, said California Department ...

Shares of Momenta took a hit after the company warned that its development of a generic version of Sanofi's blood thinner Lovenox is likely to take longer than expected. Shares slid 15 percent on the ...

The U.S. Food and Drug Administration issued a new warning on the use of the anticoagulant Lovenox in patients fitted with a spinal catheter because of the risk of spinal column bleeding and ...

Lovenox is approved in 96 countries for the treatment of thromboembolic disease, among other ailments.

LONDON (MarketWatch) -- Sanofi-Aventis on Friday said it lost a patent infringement suit filed in a U.S. district court in California against Amphastar and Teva Pharmaceutical over the Lovenox drug.